According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), the final maturity date of Ironwood Pharmaceuticals' existing revolving credit facility will remain unchanged, still set for December 31, 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US stock contracts related to AI cloud computing infrastructure collectively fell over the past 24 hours
Northland: The transaction between Mawell Technology and Lumentum highlights the scarce value of InP devices, benefiting related U.S. concept stocks
Northland Capital Markets has upgraded the ratings of Coherent and Applied Optoelectronics following MaxLinear's acquisition of Lumentum.
Goldman Sachs: Maintains "Buy" rating for EQT Energy (EQT.US); Mountain Resources acquisition has strategic significance
Goldman Sachs maintains a "Buy" rating on EQT Energy with a target price of $62.
Crypto prices
More
